Atul Kumar is a synthetic organic chemist, Professor & Chief Scientist at the Academy of Scientific and Innovative Research (AcSIR) [1] and Chairperson of Medicinal and Process Chemistry Division Central Drug Research Institute (CSIR-CDRI) [2] at Lucknow, India and a Dean at National Institute of Pharmaceutical Education and Research, Raebareli. [3]
Kumar has about 24 years experience in drug design, medicinal chemistry and Green Chemistry [4]
Dr.Kumar's major contributions are invention of Anti-osteoporosis Drug candidate CDRI-99/373 (CENTHANK), which is an currently in phase 1 clinical trial and NCE Anti-cancer Compound CDRI-S-007-1235 is currently in Pre-clinical stage. [5] [6] [7]
The Council of Scientific and Industrial Research, abbreviated as CSIR, was established by the Government of India in September 1942 as an autonomous body that has emerged as the largest research and development organisation in India. CSIR is also among the world's largest publicly funded R&D organisation which is pioneering sustained contribution to S&T human resource development in the country.
The Central Drug Research Institute is a multidisciplinary research laboratory in Lucknow, India, employing scientific personnel from various areas of biomedical sciences. Dr. Radha Rangarajan, An alumnus of Stanford University, University of Michigan, and Rockefeller University,She has been a postdoctoral fellow at Harvard School of Public Health, is the incumbent director of the Central Drug Research Institute.
Ormeloxifene, also known as centchroman, is one of the selective estrogen receptor modulators, or SERMs, a class of medication which acts on the estrogen receptor. It is best known as a nonsteroidal oral contraceptive which is taken once per week. In India, ormeloxifene has been available as birth control since the early 1990s, and it was marketed there under the trade name Saheli, currently available free-of-cost for the women in India as Chhaya (Centchroman).
Chhitar Mal Gupta is an Indian molecular biologist and academic, known for researches on transbilayer phospholipid asymmetry in biological membranes., drug targeting in parasitic diseases and characterization of structure and function of Leishmania actin and actin binding proteins. He is former director of the Central Drug Research Institute, Lucknow and the Institute of Microbial Technology, Chandigarh. A Distinguished Biotechnology Fellow and Distinguished Biotechnology Research Professor of the Department of Biotechnology, Government of India, he is an elected fellow of The World Academy of Sciences, Indian Academy of Sciences, Indian National Science Academy, National Academy of Sciences, India and the National Academy of Medical Sciences. The Council of Scientific and Industrial Research, the apex agency of the Government of India for scientific research, awarded him the Shanti Swarup Bhatnagar Prize for Science and Technology, one of the highest Indian science awards, in 1985, for his contributions to biological sciences.
Samir Kumar Brahmachari is an Indian biophysicist and Former Director General of the Council of Scientific & Industrial Research (CSIR) and Former Secretary, Department of Scientific and Industrial Research (DSIR), Government of India. He is the Founder Director of Institute of Genomics and Integrative Biology (IGIB), New Delhi and the Chief Mentor of Open Source for Drug Discovery (OSDD) Project. He is the recipient of J.C Bose Fellowship Award, DST (2012). In addition, he is one of the featured researchers in the India Cancer Research Database developed by Institute of Bioinformatics (IOB), Bangalore with support from the Department of Biotechnology, Government of India.
Garikapati Narahari Sastry is an Indian chemist. He has taken charge as Director of CSIR-North East Institute of Science and Technology, Jorhat, Assam on 19 February 2019. After taking charge as the Director, he has worked towards converting knowledge in the areas of computational modelling and Artificial intelligence from basic to translational research, by working closely with society and industry. Ultimately, revitalizing the strength of science and technology is essential in achieving the self-reliant and strong India. In the era of Industry 4.0 and 5.0, combining our traditional wisdom with modern science appear to be indispensable in the sectors such as Education, Health, Agriculture, Industrial and Societal development at large. Prior to joining as the Director, he headed the Molecular Modelling Division at the CSIR Indian Institute of Chemical Technology in Hyderabad, India. Sastry has made pioneering contributions in the areas of computational chemistry and computational biology.
National Institute of Pharmaceutical Education and Research, Raebareli (NIPER-Raebareli) established 2008, is an Indian public pharmacy research university running from a transit campus at Lucknow, Uttar Pradesh. It a part of the seven National Institutes of Pharmaceutical Education and Research, under India's Ministry of Chemicals and Fertilizers. The institute offers Masters and Doctoral degrees in pharmaceutical sciences. As an Institute of National Importance it plays an important role in the Human Resource Development for the ever growing Indian Pharmaceutical industry, which has been in the forefront of India’s science-based industries with wide ranging capabilities in drug manufacturing.
Open Source Drug Discovery is a Council of Scientific and Industrial Research, India (CSIR)-led Team India Consortium with global participation offering a collaborative drug discovery platform for neglected tropical diseases like leishmaniasis, which draw limited attention of research-based pharmaceutical enterprises. This program has a global community with over 7500 participants from 130 countries comprising researchers, academia, students, industries, educational institutions and so on. Anyone who is committed to the discovery of drugs for neglected diseases in an open source mode can participate in the program. OSDD functions by bringing together experts from diverse backgrounds to focus on discovering and developing affordable drugs for tropical infections.
Bishnupada Mukerjee or Bishnupada Mukhopadhyaya was an Indian pharmacologist and orthopedic surgeon, known for his contributions in the fields of pharmacological research and standardization of drugs in India. The Government of India honoured him in 1962, with the award of Padma Shri, the fourth highest Indian civilian award for his services to the nation.
Harkishan Singh was Professor Emeritus at the Panjab University. He was a well recognized pharmaceutical academic, medicinal chemistry researcher and science historian. He had more than half a century experience in his respective fields to his credit. He worked at the Banaras Hindu University, University of Saugar, and the Panjab University in India, and abroad at the University of Maryland, University of Mississippi and the University of London.
Vinod Bhakuni (1962–2011) was an Indian molecular biophysicist and the head of the Molecular and Structural Biology Division of the Central Drug Research Institute (CDRI). He was the founder of the Protein Chemistry laboratory of CDRI and was known for his contributions to the study of protein folding. A recipient of the National Bioscience Award for Career Development, he was an elected fellow of the Indian Academy of Sciences, Indian National Science Academy and the National Academy of Sciences, India. The Council of Scientific and Industrial Research, the apex agency of the Government of India for scientific research, awarded him the Shanti Swarup Bhatnagar Prize for Science and Technology, one of the highest Indian science awards, in 2006, for his contributions to biological sciences.
Manojit Mohan Dhar (1927–2003) was an Indian natural product chemist and the director of Central Drug Research Institute. He was known for his researches on peptides and the synthesis of the internucleotide bond and was an elected fellow of the Indian National Science Academy. The Council of Scientific and Industrial Research, the apex agency of the Government of India for scientific research, awarded him the Shanti Swarup Bhatnagar Prize for Science and Technology, one of the highest Indian science awards, in 1971, for his contributions to chemical sciences.
Dumbala Srinivasa Reddy is currently Director CSIR-IICT Indian Institute of Chemical Technology Hyderabad India, he has additional charge of CSIR-IIIM CSIR-Institute of Integrative Medicine at Jammu and CSIR-CDRI CSIR-Drug Research Institute at Lucknow, India.
Chinmoy Sankar Dey is an Indian molecular biologist and a professor at Kusuma School of Biological Sciences of the Indian Institute of Technology, Delhi. Known for his research on insulin resistance, Dey's is a J. C. Bose National Fellow of the Department of Science and Technology and an elected fellow of the National Academy of Sciences, India and the Indian National Science Academy. The Council of Scientific and Industrial Research, the apex agency of the Government of India for scientific research, awarded him the Shanti Swarup Bhatnagar Prize for Science and Technology, one of the highest Indian science awards for his contributions to Medical Sciences in 2003. He is also a recipient of the National Bioscience Award for Career Development of the Department of Biotechnology.
Anil Koul is a scientist and former Director of the CSIR-Institute of Microbial Technology (IMTECH), a premier biomedical and biotechnology research institution under Council of Scientific and Industrial Research (CSIR) under Ministry of Science and Technology, Govt. of India.
Madhu Dikshit is an Indian cardiovascular biologist, pharmacologist, who served as (2015–2017) director of the Central Drug Research Institute of the Council of Scientific and Industrial Research. Known for her studies on cardiovascular pathologies such as thrombosis, she is also an adjunct professor at Carleton University. Her studies have been documented by way of a number of articles and ResearchGate, an online repository of scientific articles has listed 204 of them. All the three major Indian science academies namely Indian Academy of Sciences, National Academy of Sciences, India and Indian National Science Academy have elected her as their fellow and she is also a recipient of the Young Scientists Medal (1989) as well as the Professor K. P. Bhargava Memorial Medal (1999) of the Indian National Science Academy. The Department of Biotechnology of the Government of India awarded her the National Bioscience Award for Career Development, one of the highest Indian science awards, for her contributions to biosciences in 2000.
Seema Bhatnagar is an Indian scientist, working in the field of anticancer drug discovery. She primarily works on synthetic chemistry approaches for targeted delivery of anticancer drugs in breast cancer.
BGR-34 is an Ayurvedic-derived product that is sold in India as an over-the-counter pill for the management of type 2 diabetes. It was developed in 2015 by two government-owned laboratories and launched commercially in 2016. It has been tested in only one, modest-sized, human trial. The drug has been heavily criticized, and without more clinical trials, its efficacy remains unproven. The manufacturers have refused to acknowledge the claims of inefficacy and other concerns.
Rajender Singh Sangwan is an Indian biochemist, professor and agriculture biotechnologist. He is the Director and Vice-Chancellor of Academy of Scientific and Innovative Research (AcSIR), India. He was the founder CEO of Center of Innovative and Applied Bioprocessing (CIAB), Mohali. He was also the former executive director of National Agri-Food Biotechnology Institute (NABI), Mohali. Known for his contributions to the field of food and agricultural biotechnology, he is an elected fellow of Indian National Science Academy (INSA), National Academy of Sciences, India (NASI) and National Academy of Agricultural Sciences (NAAS).
T Govindaraju is a professor in the Bioorganic Chemistry Laboratory at Jawaharlal Nehru Centre for Advanced Scientific Research, Bengaluru. The researchers in the Bioorganic Chemistry Laboratory work in areas which lie at the intersection of chemistry, biology and biomaterials science, and in particular, on problems related to Alzheimer's disease, peptide chemistry, molecular probes, molecular architectonics, nanoarchitectonics and biomimetics.
  | This article about an Indian scientist is a stub. You can help Wikipedia by expanding it. |